Harbour Investments’s KALA BIO KALA Stock Holding History

Harbour Investments’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5	Hold	3	–	–	﹤0.01%	4752
2026 Q1	$26	Buy	+3	New	+$63	﹤0.01%	4613

Other funds holding KALA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Harbour Investments's KALA Position: Q2 2026 in Review

Harbour Investments held its KALA BIO (KALA) position steady in Q2 2026 at 3 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #4752.

Harbour Investments first reported a position in KALA in Q1 2026 and has held it in 2 quarters since. The position peaked at $26 in Q1 2026. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

Harbour Investments held 3 shares of KALA BIO worth $5 as of Q2 2026.
Harbour Investments left its KALA BIO share count unchanged in Q2 2026.
KALA BIO made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4752 holding.
Harbour Investments first reported a position in KALA BIO in Q1 2026 and has held it in 2 quarters since.
Harbour Investments's KALA BIO position peaked at $26 in Q1 2026.
14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.